» Articles » PMID: 25648217

Epidemiological Monitoring of Nosocomial Infections Caused by Acinetobacter Baumannii

Overview
Journal Med Arch
Specialty General Medicine
Date 2015 Feb 5
PMID 25648217
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Acinetobacter baumannii is a frequent cause of infections in hospitals around the world, which is very difficult to control and treat. It is particularly prevalent in intensive care wards.

Aim: The main objective of the research was to establish the application of epidemiological monitoring of nosocomial infections (NIs) caused by A. baumannii in order to determine: the type and distribution of NIs, and to investigate antimicrobial drug resistance of A. baumannii.

Material And Methods: 855 patients treated at the Clinic of Anesthesiology and Reanimation, University Clinical Center Tuzla during 2013 were followed prospectively for the development of NIs. Infections caused by A. baumannii were characterized by the anatomical site and antibiotics resistance profile.

Results: NIs were registered in 105 patients (12.3%; 855/105). The predominant cause of infection was A. baumannii with an incidence of 51.4% (54/105), followed by ESBL-producing Klebsiella pneumoniae with 15.2% (16/105) of cases, methicillin-resistant Staphylococcus aureus with 8.6% (9/105), and ESBL-producing Proteus mirabilis with 7.6% (8/105). According to the anatomical site, and type of NIs caused by A. baumannii, the most frequent were respiratory infections (74.1%; 40/54). Infections of surgical sites were registered in 11.1% (6/54) of cases, while bloodstream infections in 9.2% (5/54). A. baumannii isolates tested resistant against most antibiotics examined, but showed a high degree of susceptibility to tobramycin (87%; 47/54) and colistin (100%; 54/54).

Conclusion: The increasing incidence of multi- and extensively drug-resistant Acinetobacter spp. emphasizes the importance of administration of an adequate antibiotic strategy and the implementation of strict monitoring of the measures for controlling nosocomial infections.

Citing Articles

Insertion Sequences within Oxacillinases Genes as Molecular Determinants of Resistance to Carbapenems-A Pilot Study.

Depka D, Bogiel T, Rzepka M, Gospodarek-Komkowska E Microorganisms. 2024; 12(10).

PMID: 39458366 PMC: 11510033. DOI: 10.3390/microorganisms12102057.


Nosocomial carbapenem-drug resistant Acinetobacter baumannii, related factors and clinical outcomes in Northeast Iran.

Alidoosti Y, Mehravar F, Shirzad-Aski H, Golsha R BMC Infect Dis. 2024; 24(1):1103.

PMID: 39367345 PMC: 11451023. DOI: 10.1186/s12879-024-09972-z.


Identification of a Family of Glycoside Derivatives Biologically Active against and Other MDR Bacteria Using a QSPR Model.

Palacios-Can F, Silva-Sanchez J, Leon-Rivera I, Tlahuext H, Pastor N, Razo-Hernandez R Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259397 PMC: 9964118. DOI: 10.3390/ph16020250.


Synergistic Antimicrobial Effect of Colistin in Combination with Econazole against Multidrug-Resistant Acinetobacter baumannii and Its Persisters.

Xie M, Chen K, Chan E, Chen S Microbiol Spectr. 2022; 10(3):e0093722.

PMID: 35467374 PMC: 9241926. DOI: 10.1128/spectrum.00937-22.


Conventional and Real-Time PCR Targeting Genes as Reliable Methods for a Rapid Detection of Carbapenem-Resistant Clinical Strains.

Depka D, Mikucka A, Bogiel T, Rzepka M, Zawadka P, Gospodarek-Komkowska E Antibiotics (Basel). 2022; 11(4).

PMID: 35453207 PMC: 9032895. DOI: 10.3390/antibiotics11040455.


References
1.
Villegas M, Hartstein A . Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol. 2003; 24(4):284-95. DOI: 10.1086/502205. View

2.
McGuckin M, Waterman R, Govednik J . Hand hygiene compliance rates in the United States--a one-year multicenter collaboration using product/volume usage measurement and feedback. Am J Med Qual. 2009; 24(3):205-13. DOI: 10.1177/1062860609332369. View

3.
Young L, Sabel A, Price C . Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit. Infect Control Hosp Epidemiol. 2007; 28(11):1247-54. DOI: 10.1086/521660. View

4.
Dima S, Kritsotakis E, Roumbelaki M, Metalidis S, Karabinis A, Maguina N . Device-associated nosocomial infection rates in intensive care units in Greece. Infect Control Hosp Epidemiol. 2007; 28(5):602-5. DOI: 10.1086/513618. View

5.
Wendt C, DIETZE B, Dietz E, Ruden H . Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol. 1997; 35(6):1394-7. PMC: 229756. DOI: 10.1128/jcm.35.6.1394-1397.1997. View